SCOPUS 정보 검색 플랫폼

Applied Biochemistry and Biotechnology - Part B Molecular Biotechnology

Volumn 21, Issue 1, 2002, Pages 57-83

Validation of biopharmaceutical purification processes for virus clearance evaluation

(1) Darling, Allan a

a BioReliance Corporation (United States)

Author keywords

Biopharmaceutical; Biosafety testing; Viral clearance; Viral safety; Viral validation

Indexed keywords

CYCLIC GMP; VACCINE;

ACCURACY; BIOSAFETY; BLUETONGUE ORBIVIRUS; CELL CULTURE; DILUTION CURVE; DRUG PURIFICATION; DRUG SAFETY; GOOD MANUFACTURING PRACTICE; HEPATITIS A VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN RHINOVIRUS; NONHUMAN; PARVOVIRUS; POLYOMA VIRUS; PSEUDORABIES HERPETOVIRUS; REVIEW; VALIDATION PROCESS; VIRAL CONTAMINATION; VIRUS DETECTION; ANIMAL VIRUS; VIRAL CLEARANCE;

ANIMALIA; BLUETONGUE VIRUS; HEPATITIS A VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN RHINOVIRUS SP.; ORBIVIRUS; PARVOVIRUS; POLYOMAVIRUS; RHINOVIRUS; SUID HERPESVIRUS 1;

ANIMALS; PURIFICATION; VIRUSES; WELL TESTING;

BIOPHARMACEUTICAL; BIOPHARMACEUTICAL PRODUCTS; DOWNSTREAM PURIFICATIONS; INHERENT LIMITATIONS; MANUFACTURING PROCESS; PURIFICATION PROCESS; VIRAL CLEARANCE; VIRAL VALIDATION;

SAFETY TESTING;

EID: 0036229888 PISSN: 10736085 EISSN: None Source Type: Journal
DOI: 10.1385/mb:21:1:057 Document Type: Review

Times cited : (40)

References (45)

1
- 0008851194
- Biologicals Control Act of 1902 (1902)

2
- 0002176672
- Observation on the occurrence of icterus in Brazil following vaccination against yellow fever
- (1942) Am. J. Hyg. , vol.36 , pp. 68-116
- Fox, J.P.¹ Lennette, E.H.² Manso, C.³ Aquiar, J.R.⁴

3
- 0013888926
- Contaminant viruses in two live virus vaccines produced in chick cells
- (1966) J. Hyg. (Cambridge) , vol.64 , pp. 1-6
- Harris, R.J.C.¹ Dougherty, R.M.² Biggs, P.M.³ Payne, L.N.⁴ Goffe, A.P.⁵ Churchill, A.E.⁶

4
- 0008831791
- Scient. Publ. No. 147, Washington D.C., Pan American Health Organization, WHO
- (1967) Contemporary problems in regulating the potency and safety of viral vaccines, in First International Conference on Vaccines against Viral and Rickettsial Diseases of Man , pp. 577-580
- Murray, R.¹

5
- 0022416003
- Potential epidemic of Creutzfeld-Jacob disease from human growth hormone therapy
- (1985) N. Engl. J. Med. , vol.313 , pp. 728-731
- Brown, P.¹ Gajdusek, D.C.² Gibbs C.J., Jr.³ Asher, D.H.⁴

6
- 0029790712
- Virus Inactivation in blood
- (1996) AIDS , vol.10 , pp. 1183-1190
- Ben-Hur, E.¹ Horowitz, B.²

7
- 0030334226
- Dev. Biol. Stand., Basel Karger
- (1996) Experience with viral contamination in cell culture, in Viral Safety and Evaluation of Viral Clearance from Biopharmaceutical Products , vol.88 , pp. 49-56
- Garnick, R.L.¹

8
- 0008813886
- January, Washington DC
- (1996) Presentation at BioEast Meeting
- Willkommen, H.¹

9
- 0030174910
- Detection of bovine polyomavirus contamination in fetal bovine sera and modified live viral vaccines using polymerase chain reaction
- (1996) Biologicals , vol.24 , Issue.2 , pp. 131-135
- Kappeler, A.¹ Lutz-Wallace, C.² Sapp, T.³ Sidhu, M.⁴

10
- 0028264382
- Evidence of pestivirus RNA in human virus vaccines
- (1994) J. Clin. Microbiol. , vol.32 , Issue.6 , pp. 1604
- Harasawa, R.¹ Tomiyama, T.²

11
- 0029585222
- Demonstration and genotyping of pestivirus RNA from mammalian cell lines
- (1995) Microbiol. Immunol. , vol.39 , Issue.12 , pp. 979-985
- Harasawa, R.¹ Mizusawa, H.²

12
- 0028488843
- Bluetongue virus: Contamination of vaccine
- (1994) J. Am. Vet. Med. Assoc. , vol.205 , Issue.3 , pp. 407
- O'Toole, D.¹ Van Campen, H.² Woodard, L.³

13
- 0030346897
- Abortion and death in pregnant bitches associated with a canine vaccine contaminated with blue-tongue virus
- Dev. Biol. Stand., Basel Karger
- (1996) Viral Safety and Evaluation of Viral Clearance from Biopharmaceutical Products , vol.88 , pp. 219-220
- Levings, R.I.¹ Wilbur, L.A.² Evermann, J.F.³

14
- 0027764485
- Contamination of genetically engineered CHO-cells by epizootic haemorrhagic disease virus (EHDV)
- (1993) Biologicals , vol.21 , Issue.3 , pp. 207-214
- Rabenau, H.¹ Ohlinger, V.² Anderson, J.³

15
- 0028961367
- Detection by PCR of wild-type canine parvovirus which contaminates dog vaccines
- (1995) J. Clin. Microbiol. , vol.33 , Issue.1 , pp. 110-113
- Senda, M.¹ Parrish, C.R.² Harasawa, R.³

16
- 13244300646
- Molecular cloning and disease association of hepatitis G virus: A transfusion-transmissible agent
- (1996) Science , vol.27 , pp. 505-508
- Linnen, J.¹ Wages, J.² Zhang-Keck, Z.Y.³

17
- 0029655296
- Primary characterization of a herpesvirus agent associated with Kaposi's sarcoma
- (1996) J. Virol. , vol.70 , pp. 549-558
- Moore, S.J.¹ Gao, G.² Dominguez, E.³

18
- 0008811421
- (1991) Note for Guidance: Validation of Virus Removal and Inactivation Procedures III/8115/89

19
- 0008812770
- Office of Biologics Research and Review, Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use (Food and Drug Administration, Bethesda, MD, 1987)

20
- 0005613142
- Notice on the registration of drugs: Requirements for validation studies to demonstrate the virus safety of drugs derived from human blood or plasma
- (1994) Bundesanzeiger , vol.84 , pp. 4742-4744

22
- 0008851427
- The European Agency for the Evaluation of Medicinal Products, Human Medicines Evaluation Unit - CPMP Biotechnology Working Party Note for Guidance on Virus Validation Studies: the Design, Contribution and Interpretation of Studies Validating the Inactivation and Removal of Viruses, (CPMP/BWP/268/95 Final Version 2, Canary Wharf, London, 1996)

23
- 0008839472
- The European Agency for the Evaluation of Medicinal Products, Human Medicines Evaluation Unit - CPMP Biotechnology Working Party Medicinal Products Derived from Human Plasma, (CPMP/BWP/268/95 Final Version 2, Canary Wharf, London, 1996)

24
- 0008838666
- Office of Biologics Research and Review, Points to Consider in the Characterization of Cell Lines Used to Produce Biologicals (Food and Drug Administration, Bethesda, MD, 1993)

25
- 0008828535
- Office of Biologics Research and Review, Draft Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use (Food and Drug Administration, Bethesda, MD, 1994)

26
- 0008833021
- Center for Biologics Evaluation and Research, Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use (Food and Drug Administration, Rockville, MD, 1997)

27
- 0008813387
- ICH Topic Q5A. Step 4 Consensus Guideline, Quality of Biotechnological Products: Viral Safety Evaluation of Biotechnology Products Derived From Cell Lines of Human or Animal Origin, CPMP/ICH/295/95. The European Agency for the Evaluation of Medicinal Products, Human Medicines Evaluation Unit, Canary Wharf, London (1997)

28
- 0029806575
- Validation: Ensuring the accuracy of scaled-down chromatography models
- (1996) Biopharm. , vol.9 , Issue.9 , pp. 51-54
- Sofer, G.¹

29
- 0008811631
- Validation of chromatographic procedures used in the fractionation of plasma derivatives
- Spier, R. E., Griffith, J. B., and Berthold, W., eds. Butterworth-Heinemann Ltd., Oxford
- (1994) Animal Cell Technology: Products of Today, Prospects for Tomorrow , pp. 567-570
- Darling, A.J.¹ Kreuzberg-Duffy, U.² Borland, L.³ Morrow, A.⁴ Berglof, J.H.⁵ Andersson, I.⁶

30
- 84886493425
- Freezing and thawing serum and other biological materials
- (1992) Art to Science , vol.11 , Issue.2 , pp. 1-7

31
- 0003228192
- ICH guideline on "validation of analytical procedures: Definitions and terminology; availability,"
- 1 March
- (1995) Federal Register , vol.4 , pp. 11259-11262

32
- 0029852635
- Process validation for virus removal. Considerations for design of process studies and viral assays
- (1996) BioPharm. , vol.9 , Issue.9 , pp. 42-50
- Darling, A.J.¹ Spaltro, J.J.²

33
- 0003153125
- Bibrack, B. and Wittmann, G., eds. Stuttgart: Fischer Verlag
- (1974) Virologische Arbeitsmethoden , pp. 37-39
- Spearman, C.¹ Kaerber, G.²

34
- 0002570977
- Validation of immunological and biological assays
- (1995) Biopharm. , vol.NOV. , pp. 36-42
- Little, L.E.¹

35
- 0008833022
- United States vs Barr Laboratories, Inc.; Civil Action No. 92-1744, U.S. District Court for the District of New Jersey; 812F. Supp. 458; 1993 U.S. Dist. Lexis 1932; 4 February 1993, as amended 30 March 1993

36
- 0029110015
- The prion diseases
- (1995) Sci. Am. , vol.272 , Issue.1 , pp. 48-51
- Prusiner, S.B.¹

37
- 0028986377
- On safari with PrP: Prion diseases of animals
- (1995) Trends Microbiol. , vol.3 , Issue.4 , pp. 141-147
- Westaway, D.¹ Carlson, G.A.² Prusiner, S.B.³

38
- 0008838008
- Note for Guidance on Minimizing the Risk of Transmitting Animal Spongiform Encephalopathy Agents via Human and Veterinary Medicinal Products - CPMP/CVMP EMEA/410/01 - February 2001

39
- 0008851195
- Notification of the Safety Requirements for Pharmaceuticals Made From Body Components of Cattle, Sheep or Goats for the Protection Against the Risk of Transmission of BSE and Scrapie - BGA, Germany Feb. 1994

40
- 0008862725
- Notification Concerning the Approval Registration of Pharmaceuticals of 28 March 1996 Protection Against Pharmaceutical Product Risks, Level II BfArM, Federal Institute for Pharmaceuticals and Medicinal Products, Germany

41
- 0342951746
- A new variant of Creutzfeldt-Jakob disease in the UK
- (1996) Lancet , vol.374 , pp. 921-925
- Will, R.G.¹ Ironside, J.W.² Zeilder, M.³

42
- 0029947694
- BSE transmission to macaques
- (1996) Nature , vol.381 , pp. 743
- Lasmezas, C.I.¹ Deslys, J.-P.² Demaimay, R.³

43
- 0028102794
- Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein
- (1994) Proc. Natl. Acad. Sci. USA , vol.91 , pp. 9936-9940
- Telling, C.¹ Scott, M.² Hsiao, K.K.³

44
- 0034675211
- Transmission of BSE by blood transfusion in sheep
- (2000) Lancet , vol.356 , pp. 999-1000
- Houston, F.¹ Foster, J.D.² Chong, A.³ Hunter, N.⁴ Bostock, C.J.⁵

45
- 0033991241
- Monitoring plasma processing steps with a sensitive Western Blot assay for the detection of prion protein
- (2000) J. Virol. Methods , vol.84 , pp. 77-89
- Lee, D.C.¹ Stenland, C.J.² Hartwell, R.C.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.